1
|
Alabi RO, Haq Z, Bloomer MM, Afshar AR. Clinicopathologic analysis of a case of small cell lung carcinoma metastatic to the retina. Am J Ophthalmol Case Rep 2023; 31:101863. [PMID: 37351340 PMCID: PMC10282170 DOI: 10.1016/j.ajoc.2023.101863] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2022] [Revised: 04/30/2023] [Accepted: 05/21/2023] [Indexed: 06/24/2023] Open
Abstract
Purpose Tumor metastases to the retina are a relatively rare occurrence. We report a unique case of retinal metastasis of a systemic malignancy with clinical and histopathologic correlations. Observations A 62-year-old female with a history of stage IV small cell carcinoma of the lung (SCC, status post chemotherapy and maintenance immunotherapy) presented with hand motions vision and vitreous hemorrhage, status post prior vitrectomy and biopsy that was non-diagnostic. She was found to have unilateral retinal metastatic tumor and underwent a repeat vitrector-assisted biopsy which confirmed the diagnosis. The eye became blind and painful due to recurrent non-clearing vitreous hemorrhage and ghost cell glaucoma and was enucleated. Detailed histopathologic analysis of the globe confirmed small cell carcinoma metastatic to the retina and vitreous cavity and sparing the choroid. Conclusions and importance This case demonstrates the importance of maintaining a high index of suspicion for metastasis in patients with a known history of malignancy who present with new vitreoretinal lesions.
Collapse
Affiliation(s)
- Rolake O. Alabi
- Department of Ophthalmology, Wayne & Gladys Valley Center for Vision, University of California, San Francisco, San Francisco, CA, USA
| | - Zeeshan Haq
- Department of Ophthalmology, Wayne & Gladys Valley Center for Vision, University of California, San Francisco, San Francisco, CA, USA
| | - Michele M. Bloomer
- Ophthalmic Pathology Service, Department of Ophthalmology, University of California, San Francisco, San Francisco, CA, USA
| | - Armin R. Afshar
- Ocular Oncology Service and Vitreoretinal Service, Department of Ophthalmology, Wayne & Gladys Valley Center for Vision, University of California, San Francisco, San Francisco, CA, USA
- Hellen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA
| |
Collapse
|
2
|
Clinical features of retinal metastases: new cases integrated in a systematic review of the literature. Retina 2022; 42:1370-1383. [PMID: 35234674 DOI: 10.1097/iae.0000000000003459] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
PURPOSE To report a cohort of patients diagnosed with retinal metastasis (RM) and to integrate these new cases in a systematic review of the literature, analyzing the clinical features and prognosis factors of patients with RM. METHODS We conducted a retrospective multicenter study including patients with RM. We also performed a full literature review of all published cases with a diagnosis of RM. RESULTS A total of 6 new cases were described on multimodal imaging. By combining the data from the literature and from our patients, we report the characteristics of a total of 69 patients. The most frequent primary tumor sites were cutaneous melanoma (36%), lung (23%), gastro-intestinal tract (17%) and breast (12%). Multimodal imaging highlighted specific characteristics of RM. Fluorescein and indocyanine green angiography revealed early hypofluorescence followed by progressive filling of intrinsic dilated vessels. Optical coherence tomography demonstrated a hyperreflective intraretinal mass in all cases with or without subretinal fluid, hyperreflective intraretinal dots or intraretinal fluid. Ultrasonography revealed a medium-high reflective dome-shaped tumor. Fifty-nine percent of the patients died during the follow-up with a mean survival time of 8.8±8.7 months. CONCLUSION We described here the clinical spectrum of RM and highlighted specific features of the disease.
Collapse
|
3
|
Stenberg R, Mancini G, Guthrie T, Simon EL. Intraocular mass as first presenting symptom of metastatic squamous cell lung cancer. Am J Emerg Med 2021; 50:814.e1-814.e2. [PMID: 34275680 DOI: 10.1016/j.ajem.2021.06.041] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2021] [Accepted: 06/20/2021] [Indexed: 11/29/2022] Open
Abstract
Lung cancer is one of the leading causes of cancer related mortality worldwide. Currently, it is the third most common cancer behind prostate and breast cancer. Approximately 85% of all lung cancers are non-small-cell lung cancers (NSCLC). Adenocarcinoma and squamous cell carcinoma are the most common subtypes, accounting for 50% and 30% of NSCLC cases, respectively. Lung cancer is often initially found on chest x-rays and diagnosed via biopsy of the lesion. It is often diagnosed at the time of advanced or metastatic disease. The majority of lung cancers metastasize to locations such as bone, brain, adrenal glands and liver. Multiple case reports have been reported with ocular metastases, such as the choroid, iris and retina. We present a 87-year-old women whose initial emergency department presentation of squamous cell type lung cancer was an intraocular mass. To our knowledge this is the first reported case of this presentation and diagnosis within the emergency department setting.
Collapse
Affiliation(s)
- Robert Stenberg
- Cleveland Clinic Akron General, Department of Emergency Medicine, Akron, OH, Northeast Ohio Medical University, Rootstown, United States of America
| | - Gregory Mancini
- Cleveland Clinic Akron General, Department of Emergency Medicine, Akron, OH, Northeast Ohio Medical University, Rootstown, United States of America
| | - Tim Guthrie
- Cleveland Clinic Akron General, Department of Emergency Medicine, Akron, OH, Medical College of Wisconsin-Green Bay Campus, Green Bay, WI., United States of America
| | - Erin L Simon
- Cleveland Clinic Akron General, Department of Emergency Medicine, Akron, OH, Northeast Ohio Medical University, Rootstown, United States of America.
| |
Collapse
|
4
|
Ucgul AY, Ozdek S, Hasanreisoğlu M, Aydın K, Atalay HT. Rhegmatogenous retinal detachment secondary to isolated retinal metastasis from small cell lung carcinoma: An uncommon complication. Eur J Ophthalmol 2020; 31:NP11-NP14. [PMID: 31964176 DOI: 10.1177/1120672120902022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
PURPOSE To report a case of rhegmatogenous retinal detachment associated with isolated retinal metastasis from lung carcinoma. METHODS Multimodal imaging, including wide-field retinal imaging, ultrasonic imaging, and magnetic resonance imaging. RESULTS Systemic chemotherapy and cranial prophylactic radiotherapy resulted in shrinkage of these lesions and retinal breaks making them much smaller and preventing progression of retinal detachment transiently. CONCLUSION This is the first reported case of rhegmatogenous retinal detachment secondary to retinal metastasis from a lung cancer.
Collapse
Affiliation(s)
- Ahmet Yucel Ucgul
- Department of Ophthalmology, Training and Research Hospital, Abant Izzet Baysal University, Bolu, Turkey.,Department of Ophthalmology, Gazi University School of Medicine, Ankara, Turkey
| | - Sengul Ozdek
- Department of Ophthalmology, Gazi University School of Medicine, Ankara, Turkey
| | - Murat Hasanreisoğlu
- Department of Ophthalmology, Gazi University School of Medicine, Ankara, Turkey
| | - Kubra Aydın
- Department of Medical Oncology, Memorial Hospital, Ankara, Turkey
| | - Hatice Tuba Atalay
- Department of Ophthalmology, Gazi University School of Medicine, Ankara, Turkey
| |
Collapse
|
5
|
Guo Y, Wang X, Xiao J, Xu Y, Cai Y, Sun C, Ma K. Lung squamous cell carcinoma with solitary ocular metastasis and its successful treatment with thoracic surgery and chemotherapy: an interesting and rare case report. BMC Cancer 2018; 18:1004. [PMID: 30342504 PMCID: PMC6195964 DOI: 10.1186/s12885-018-4944-y] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2018] [Accepted: 10/12/2018] [Indexed: 11/10/2022] Open
Abstract
Background The incidence of ocular metastasis from lung cancer is reported to be 0.1–7%, with adenocarcinoma and small cell lung cancer accounting for the highest proportions of these cases. The majority of cases involves metastasis to more than one other distal organ in addition to the eye. Here, we report for the first time, a case of lung squamous cell carcinoma with solitary symptomatic ocular metastasis as the initial manifestation that was managed by a multidisciplinary treatment (MDT). Case presentation A woman presented at the ophthalmology department of hospital with a 1-week history of left eye pain and blurred vision. Systemic examination led to the diagnosis of central lung cancer in the right lower lobe with ocular metastasis. After consultations with an MDT, including specialists from the surgery, internal medicine, ophthalmology, radiotherapy and imaging departments, the patient underwent surgery and chemotherapy. Her eye symptoms disappeared, and the ocular lesion was well controlled without any specific ocular treatment. The patient demonstrated a prolonged progression-free survival. Conclusion This is the first report of a rare case with solitary ocular metastasis as the initial manifestation of lung squamous cell carcinoma. This rare patient was treated based on evidence-based medicine, indicating the importance of cooperation within an MDT. The successful treatment of this case was reported as a new therapeutic reference for clinicians who encounter similar cases in the future.
Collapse
Affiliation(s)
- Ye Guo
- The Jilin University First Hospital, No. 71, Xinmin Street, Changchun, Jilin, 130021, People's Republic of China
| | - Xu Wang
- The Jilin University First Hospital, No. 71, Xinmin Street, Changchun, Jilin, 130021, People's Republic of China
| | - Jun Xiao
- The Jilin University Second Hospital, No. 218, Ziqiang Street, Changchun, Jilin, 130021, People's Republic of China
| | - Yinghui Xu
- The Jilin University First Hospital, No. 71, Xinmin Street, Changchun, Jilin, 130021, People's Republic of China
| | - Yangyang Cai
- The Jilin University First Hospital, No. 71, Xinmin Street, Changchun, Jilin, 130021, People's Republic of China
| | - Chao Sun
- The Jilin University First Hospital, No. 71, Xinmin Street, Changchun, Jilin, 130021, People's Republic of China
| | - Kewei Ma
- The Jilin University First Hospital, No. 71, Xinmin Street, Changchun, Jilin, 130021, People's Republic of China.
| |
Collapse
|